Journal of Microbiology, Immunology and Infection

Aims & Scope

The journal is an open access journal, committed to disseminating information on the latest trends and advances in microbiology, immunology, infectious diseases and parasitology.

Articles on clinical or laboratory investigations of relevance to microbiology, immunology, infectious diseases, parasitology and other related fields that are of interest to the medical profession are eligible for consideration.

Article types considered include perspectives, review articles, original articles, brief reports and correspondence.

The Editorial Board of the Journal comprises a dedicated team of local and international experts in the field of microbiology, immunology, infectious diseases and parasitology.

All members of the Editorial Board actively guide and set the direction of the journal.

With the aim of promoting effective and accurate scientific information, an expert panel of referees constitutes the backbone of the peer-review process in evaluating the quality and content of manuscripts submitted for publication.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Immunology and Microbiology and Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,000.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• A systematic review of asymptomatic infections with COVID-19

  Citation: 667

  Authors: Zhiru, Yinghui, Chao, Xu, Ye, Shi, Kewei

• Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths

  Citation: 647

  Authors: Chih-Cheng, Yen Hung, Cheng-Yi, Ya-Hui, Shun-Chung, Muh-Yen, Wen-Chien, Po-Ren

• TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib

  Citation: 647

  Authors: Dandan, Xuexian O.

• Genotype and phenotype of COVID-19: Their roles in pathogenesis

  Citation: 561

  Authors: Leila, Sorayya

• Are children less susceptible to COVID-19?

  Citation: 429

  Authors: Ping-Ing, Ya-Li, Po-Yen, Yhu-Chering, Po-Ren

• ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome

  Citation: 390

  Authors: Christian A., Jean-Marc, Didier

• Treatment options for COVID-19: The reality and challenges

  Citation: 388

  Authors: Shio-Shin, Ping-Ing, Po-Ren

• Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?

  Citation: 367

  Authors: Chih-Cheng, Cheng-Yi, Po-Ren

• Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of two cases & review of the literature

  Citation: 294

  Authors: Sarah H., Jaffar A., Ziad A.

• Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria

  Citation: 257

  Authors: Pooi Yin, Ramona